OPTN/SRTR 2019 Annual Data Report: Pancreas. Read more about OPTN/SRTR 2019 Annual Data Report: Pancreas.
Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement". Read more about Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement".
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant. Read more about Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
Expanding living donor liver transplantation: Report of first US living donor liver transplant chain. Read more about Expanding living donor liver transplantation: Report of first US living donor liver transplant chain.
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction. Read more about Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature. Read more about Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature.
Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Read more about Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.
Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression. Read more about Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression.
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. Read more about Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Read more about A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action.
